Barrit S
Faculté de Médecine, ULB.
Department of Neurosurgery, Boston Children's Hospital, Massachusetts.
Rev Med Brux. 2018;39(3):155-160. doi: 10.30637/2018.16-030. Epub 2018 May 30.
SAMHD1 is one of seven known genes responsible for Aicardi-Goutières syndrome. It has the particularity to associate to this rare pediatric encephalopathy with autoimmune manifestations, a cerebral vasculopathy type Moyamoya. This condition has only been recently reported, less than fifty times in the literature. Our clinical case is a 11 year old boy from an inbred union whose clinical diagnosis confirmed genetically and followed by a review of current data determined an ad hoc management, presently described. He underwent indirect neurosurgical revascularization by a multiple burr hole technique. Through this clinical case, we tried taking stock of what we know -clinical, physiopathological and therapeutical aspects- given the rarity of this disease, first on the syndrome as such, then on the peculiarities of the gene mutations of interest.
SAMHD1是已知的与Aicardi-Goutières综合征相关的七个基因之一。它的特殊之处在于与这种伴有自身免疫表现的罕见小儿脑病、一种烟雾病类型的脑血管病相关联。这种病症直到最近才被报道,文献中报道不到五十次。我们的临床病例是一名来自近亲联姻家庭的11岁男孩,其临床诊断通过基因检测得以确认,随后对现有数据进行回顾确定了一种专门的治疗方案,现予以描述。他通过多钻孔技术接受了间接神经外科血管重建术。鉴于这种疾病的罕见性,通过这个临床病例,我们首先尝试总结我们所了解的——临床、生理病理和治疗方面——关于该综合征本身的情况,然后是相关基因突变的特殊性。